ePI IG for APAC markets
0.1.0 - ci-build
ePI IG for APAC markets, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cander2/aseanepi/ and changes regularly. See the Directory of published versions
Controlled terminology is a key part of FHIR since it provides a consistent and standardized method for naming identified terms.
Each Resource contains a set of elements and attributes. Some elements are bound to a controlled terminology. The bindings offer various degrees of flexibility:
The following is a list of controlled terminologies that are preferred because they support international harmonization. Refer to Appendix XX for a complete list in-scope elements and their corresponding terminologies.
Topic | Type of standard | Preferred Standard |
---|---|---|
Language | International | ISO 639-1 (Two letter) |
Country code | International | ISO 3166-1 alpha-2 (Two letter) |
Pack Type | EU | EDQM Standard Terms |
Pack Material | EU | EDQM Standard Terms |
Route of administration | EU | EDQM Standard Terms |
Pharmaceutical dose form | EU | EDQM Standard Terms |
Combined Pharmaceutical dose form | EU | EDQM Standard Terms |
Unit of presentation | EU | EDQM Standard Terms |
Units of Measure | International | EDQM Standard Terms |
Substance code | US | FDA’s UNII (from Global Substance Registration System (G-SRS)) |
Substance name | International | WHO INN |
Colour | US | FDA SPL Resources |
Shape | US | FDA SPL Resources |
Flavour | US | FDA SPL Resources |